Sutro Biopharma
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Sutro Biopharma's past years’ income statements indicate that its last revenue has increased compared to the previous period by 127% to $153,731,000. The net income raised on -$106,793,000 and profit margin reached -69%. Total operating expenses were $243,009,000.

Profit Margin

Sutro Biopharma, Inc. (NASDAQ:STRO): Profit margin
2016 59.73M 1.70M 2.85%
2017 51.74M -19.68M -38.05%
2018 38.41M -35.31M -91.93%
2019 42.73M -55.74M -130.44%
2020 42.72M -36.20M -84.75%
2021 61.88M -108.67M -175.62%
2022 67.77M -119.20M -175.89%
2023 153.73M -106.79M -69.47%

STRO Income Statement (2016 – 2023)

2023 2022 2021 2020 2019 2018 2017 2016
Revenue
Revenue
153.73M67.77M61.88M42.72M42.73M38.41M51.74M59.73M
Cost of revenue
6.81M8.28M9.77M76.96M65.61M051.89M0
Gross profit
146.91M59.48M52.10M-34.23M-22.87M38.41M-156K59.73M
Operating exp.
Research and development
180.42M137.17M104.4M76.96M65.61M54.26M54.63M43.55M
Selling and marketing
00000000
Total operating expenses
243.00M196.71M160.40M113.77M98.20M75.64M71.01M58.36M
Operating income
-89.27M-128.94M-98.52M-71.05M-55.46M-37.22M-19.27M1.36M
Other income (expenses), net
677K12.23M-7.01M38.92M-276K1.91M-416K87K
Income before tax
-88.60M-116.70M-105.53M-32.12M-55.74M-35.31M-19.68M1.70M
Income tax expense
18.19M2.5M3.13M4.07M03.52M535K87K
Net income
-106.79M-119.20M-108.67M-36.20M-55.74M-35.31M-19.68M1.70M
Earnings per share
Basic EPS
-1.78-2.35-2.36-1.11-2.43-6.13-2.810.24
Diluted EPS
-1.78-2.35-2.36-1.11-2.43-6.13-2.810.24
Data sourceData sourceData sourceData sourceData sourceData source